Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Viatris

Status and phase: Completed; Phase 3

Conditions: Urinary Incontinence

Treatments: Drug: tolterodine extended release capsule

Study type: Interventional

Funder types: Industry

Identifiers

NCT00139724

A6121112

Details and patient eligibility

About

To evaluate efficacy of tolterodine extended release formulation compared with immediate release formulation in subjects with symptoms of overactive bladder

Enrollment: 260 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with a diagnosis of overactive bladder.

Exclusion criteria

• Subjects with significant stress incontinence as determined by the investigator.
• Subjects with recurrent urinary tract infections defined as treated for UTI; 5 times in the last year.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind